AbstractBackgroundEarly resuscitation after trauma-hemorrhagic shock (HS) with plasma rather than crystalloid may ameliorate systemic endothelial cell (EC) injury and dysfunction (endotheliopathy of trauma [EOT]). We postulated that endothelial lined microfluidic networks would be a useful platform to study the endothelial cell activation/injury under flow conditions to mimic HS. We then used the microfluidic system to further characterize the protective effects and optimal timing of plasma infusion on the development of “EOT” in our model.MethodsHuman umbilical vein endothelial cells (HUVEC) were added to microfluidic flow channels and after overnight perfusion the cells were subsequently treated with epinephrine (epi) and exposed to hypoxia reoxygenation (HR). Media alone or 5% human plasma was perfused either immediately following treatment (early plasma) or after a 3 hr. delay (late plasma). Glycocalyx injury was indexed by fluorescent microscopy and shedding of syndecan-1 and hyaluronic acid (HLA). Endothelial markers of activation/injury were also measured and included soluble thrombomodulin (sTM), tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI-1) and angiopoietin 1 and 2 (Ang-1 and 2). Sheddase activity was indexed by ADAM metallopeptidase domain 17 (ADAM-17).ResultsEndothelial cell and glycocalyx barrier function studied using microfluidic devices are a more realistic model of the glycocalyx endothelial vascular barrier than studies performed on endothelial cells using static (no flow) conditions. Conditions that mimic the internal mileau following hemorrhagic shock result in glycocalyx degradation and an inflammatory prothrombotic response by the endothelium. “Early” use of plasma in the microfluidic channel perfusate mitigated against these effects. Later perfusion with plasma had no protective effect.ConclusionA temporal effect to plasma administration was noted in our biomimetic model of the endothelial vascular barrier following shock. This suggests a protective role to “early” plasma administration in the severely injured patient. Background Early resuscitation after trauma-hemorrhagic shock (HS) with plasma rather than crystalloid may ameliorate systemic endothelial cell (EC) injury and dysfunction (endotheliopathy of trauma [EOT]). We postulated that endothelial lined microfluidic networks would be a useful platform to study the endothelial cell activation/injury under flow conditions to mimic HS. We then used the microfluidic system to further characterize the protective effects and optimal timing of plasma infusion on the development of “EOT” in our model. Methods Human umbilical vein endothelial cells (HUVEC) were added to microfluidic flow channels and after overnight perfusion the cells were subsequently treated with epinephrine (epi) and exposed to hypoxia reoxygenation (HR). Media alone or 5% human plasma was perfused either immediately following treatment (early plasma) or after a 3 hr. delay (late plasma). Glycocalyx injury was indexed by fluorescent microscopy and shedding of syndecan-1 and hyaluronic acid (HLA). Endothelial markers of activation/injury were also measured and included soluble thrombomodulin (sTM), tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI-1) and angiopoietin 1 and 2 (Ang-1 and 2). Sheddase activity was indexed by ADAM metallopeptidase domain 17 (ADAM-17). Results Endothelial cell and glycocalyx barrier function studied using microfluidic devices are a more realistic model of the glycocalyx endothelial vascular barrier than studies performed on endothelial cells using static (no flow) conditions. Conditions that mimic the internal mileau following hemorrhagic shock result in glycocalyx degradation and an inflammatory prothrombotic response by the endothelium. “Early” use of plasma in the microfluidic channel perfusate mitigated against these effects. Later perfusion with plasma had no protective effect. Conclusion A temporal effect to plasma administration was noted in our biomimetic model of the endothelial vascular barrier following shock. This suggests a protective role to “early” plasma administration in the severely injured patient. Correspondence: Lawrence N. Diebel MD, Michael and Marian Ilitch Department of Surgery, 6C University Health Center, 4201 Saint Antoine, Detroit, MI 48201, Phone: 313-577-5314, Fax: 313-577-5310, Email: ldiebel@med.wayne.edu Conflicts of interest to disclose: None This study was presented at the 75th annual meeting of the AAST, September 13-16, 2017, in Baltimore, MD. © 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2BUaWa9
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
[PDF] Καρκίνος του στομάχου -- Αλέξανδρος Γ. Σφακιανάκης Αναπαύσεως 5 Άγιος Νικόλαος Λασιθίου 72100 2841026182
-
P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters P2Y2 Nucleotide ...
-
Abstract Introduction In recent years, platelet-rich plasma (PRP) has emerged as a promising autologous biological treatment modality fo...
-
Rehab patients are friends and co-workers, which requires additional awareness for rehab medical personnel and preplanning to administer ove...
-
Tales from the Night:: Emergency MR Imaging in Pediatric Patients after Hours Publication date: May 2019 Source: Magnetic Resonance Imaging...
-
blood bank stuff: The basics of crit care transfusion medicine EMCrit by Scott Weingart . from Emergency Medicine via xlomafota13 on I...
-
DELAYED RESPONSE: It is yet another delayed ambulance response to an emergency in D.C. With no ambulance in sight, a man suffering from mult...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου